Femring | Estradiol 0.05 Mg Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Femring | Estradiol 0.05 Mg while breastfeeding. We will also discuss about common side effects and warnings associated with Femring | Estradiol 0.05 Mg.

What is Femring | Estradiol 0.05 Mg used for?

Femring is an estrogen indicated for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause (1.2) 1.1 T reatment of Moderate to Severe Vasomotor Symptoms due to Menopause . 1.2 Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause.

I am breastfeeding mother and I am using Femring | Estradiol 0.05 Mg. Can it have any bad effect on my kid? Shall I search for better alternative?

Femring | Estradiol 0.05 Mg low risk for breastfeeding
Estradiol is the one and only active ingredient present in Femring | Estradiol 0.05 Mg. Estradiol in itself is a low risk drug for lactation so it is easy to understand that Femring | Estradiol 0.05 Mg also comes in category of Low Risk item while breastfeeding. Below is the summary of Estradiol in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Femring should not be used during lactation. Estrogen administration to nursing women has been shown to decrease the quantity and quality of the breast milk. Detectable amounts of estrogens have been identified in the breast milk of women receiving estrogen-alone therapy. Caution should be exercised when Femring is administered to a nursing woman.

Femring | Estradiol 0.05 Mg Breastfeeding Analsys

Estradiol while Breastfeeding

Low Risk

CAS Number: 50-28-2

A natural Estrogen that is marketed for oral, injection and topical administration (skin and vaginal).On the chemical form of valerate, it is used in association with a progestin as a combined birth-control compound (e.g. Estradiol + Dienogest) Estradiol is excreted into breast milk in clinically non-significant amount (Nilson 1978) and no problems have been observed in infants whose mothers were treated (Pinheiro 2016). Plasma levels of these infants were undetectable or very low (Pinheiro 2016). After administration in the form of transdermal patches milk levels have been undetectable (Pinheiro 2016, Perheentupa 2004). Despite these data, an older publication associated the use of transdermal estradiol with a case of jaundice and poor weight gain (Ball 1999).There is greater passage to milk when the administration is vaginal. There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartumThey may reduce the protein content of the milk. No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. Estrogen exposure in childhood or adolescence, does not influence the subsequent production of milk. The American Academy of Pediatrics states that this medication is usually compatible with breastfeeding.

Femring | Estradiol 0.05 Mg Breastfeeding Analsys - 2

Estradiol while Breastfeeding

CAS Number: 50-28-2

Femring | Estradiol 0.05 Mg and breastfeeding

Limited information on the use of estradiol during breastfeeding indicates that the route of administration and dosage form have influences on the amount transferred into breastmilk. Vaginal administration results in measurable amounts in milk, but transdermal patches do not. Maternal doses of up to 200 mcg daily transdermally do not increase estradiol or estriol in breastfed infants or cause any adverse effects in breastfed infants. Vaginal administration results in unpredictable peak times for estradiol in breastmilk, so timing of the dose with respect to breastfeeding is probably not useful. A case report of inadequate milk production and inadequate infant weight gain was possibly caused by transdermal estradiol initiated on the first day postpartum, but 2 small studies found no such effect when the drug was initiated after lactation was well established.

Is Femring | Estradiol 0.05 Mg safe while breastfeeding

What should I do if already breastfed my kid after using Femring | Estradiol 0.05 Mg?

Femring | Estradiol 0.05 Mg is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Femring | Estradiol 0.05 Mg so you should inform him based on your convenience.

I am nursing mother and my doctor has suggested me to use Femring | Estradiol 0.05 Mg, is it safe?

Femring | Estradiol 0.05 Mg comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.

If I am using Femring | Estradiol 0.05 Mg, will my baby need extra monitoring?

Not much monitoring required while using Femring | Estradiol 0.05 Mg

Who can I talk to if I have questions about usage of Femring | Estradiol 0.05 Mg in breastfeeding?

National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week